Little Upside Left in U.S. Junk Bonds: Diamond Hill
Bill Zox, CIO of Fixed income at Diamond Hill Capital Management, to discuss why there's little upside left in the high yield space. Leland Miller, CEO of China Beige Book International, on China Beig...
26 Jun 201928min
Allergan Is A Short-Term Cosmetic Fix For AbbVie: Nisen
Max Nisen, Bloomberg Opinion health care columnist, on AbbVie buying Botox maker Allergan for $63 billion. CoinShares Chairman Danny Masters discusses the bitcoin rally and Facebook's new Libra crypto...
25 Jun 201925min
Private Equity Fees Are Ripe For The ’Vanguard Effect’
Eric Balchunas, Senior ETF Analyst for Bloomberg Intelligence, on Vanguard considering offering private equity to investors. Francis Greenburger, Time Equities Chairman & CEO, discusses how the recent...
24 Jun 201927min
Fed's Williams Is Trying to Clean Up Powell's Error (Podcast)
Phil Orlando, Chief Equity Market Strategist at Federated Investors, on markets, the Fed and current investment strategy. Clint Watts, Distinguished Research Fellow at the Foreign Policy Research Ins...
21 Jun 201929min
Slack CEO, CFO On Why They Went With A Direct Listing
Mandeep Singh, Senior Tech Industry Analyst for Bloomberg Intelligence, on Slack going public in a direct listing, and Slack CEO Stewart Butterfield and CFO Allen Shim speak from the NYSE with Emily C...
20 Jun 201928min
Sell Credit On A Dovish Rally: PGIM's Mike Collins
Mike Collins, Senior Fixed Income Portfolio Manager for PGIM, on the bond market and what to expect from the Fed. Lionel Laurent, Bloomberg Opinion columnist, on Facebook's new cryptocurrency Libra, a...
19 Jun 201924min
Lighthizer Signals Progress On USMCA, But Not On China
Bloomberg's Mike McKee, International Economics & Policy correspondent, and Shawn Donnan, Senior Trade reporter, discuss what to expect from U.S. Trade Representative Robert Lighthizer testimony to th...
18 Jun 201918min
Array Deal Gives Pfizer Deep Cancer Expertise: Fazeli
Sam Fazeli, Director of Research for Bloomberg Intelligence, on Pfizer expanding its cancer platform with the $10.6 billion Array BioPharma deal. Leland Miller, CEO of China Beige Book International, ...
17 Jun 201925min
